1. Home
  2. Browse Decisions
  3. F.Supp.3d
  4. 72 F.Supp.3d
  5. 72 F.Supp.3d 549 (2014)
 

ASTRAZENECA AB v. MYLAN PHARMACEUTICALS, INC.

Civil Action No. 14-696-GMS.

72 F.Supp.3d 549 (2014)

ASTRAZENECA AB, Plaintiff, v. MYLAN PHARMACEUTICALS, INC., Defendant.

United States District Court, D. Delaware.

Signed November 5, 2014.

Attorney(s) appearing for the Case

Michael P. Kelly, Esquire , and Daniel M. Silver, Esquire , McCarter & English, LLP, counsel for plaintiff. Of counsel: Charles E. Lipsey, Esquire , James B. Monroe, Esquire , Robert F. Shaffer, Esquire , and Maximilienne Bishop, Esquire , Finnegan, Henderson, Farabow, Garret & Dunner, L.L.P.

Richard L. Horwitz, Esquire , David E. Moore, Esquire , and Erich W. Struble, Esquire , Potter Anderson & Corroon LLP, counsel for defendant. Of counsel: Joshua Mack, Esquire , and Douglas H. Carsten, Esquire , Wilson Sonsini Goodrich & Rosati.

OPINION

I. INTRODUCTION

AstraZeneca AB ("AstraZeneca") filed a complaint against defendant Mylan Pharmaceuticals, Inc. ("Mylan") on June 2, 2014, alleging patent infringement of U.S. Patent Nos. 7,951,400 ("the '400 Patent"), RE44,186 ("the '186 Patent"), and 8,628,799 ("the '799 Patent"). ...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases